Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice
Cystic fibrosis transmembrane conductance regulator (CFTR) is highly expressed on the ocular epithelium and plays a pivotal role in the fluid secretion driven by chloride transport. Dry eye disease is one of the most common diseases with limited therapeutic options. In this study, a high-throughput...
Main Authors: | Dongkyu Jeon, Ikhyun Jun, Ho K. Lee, Jinhong Park, Bo-Rahm Kim, Kunhi Ryu, Hongchul Yoon, Tae-im Kim, Wan Namkung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/9/5206 |
Similar Items
-
Isorhamnetin Ameliorates Dry Eye Disease via CFTR Activation in Mice
by: Ho K. Lee, et al.
Published: (2021-04-01) -
Apigenin Ameliorates Scopolamine-Induced Cognitive Dysfunction and Neuronal Damage in Mice
by: Yeojin Kim, et al.
Published: (2021-08-01) -
Effect of Glycyrrhizic Acid on Scopolamine-Induced Cognitive Impairment in Mice
by: Ju Yeon Ban, et al.
Published: (2020-05-01) -
Ameliorating the effect of Zingiber officinale (ginger) hydroethanolic extract on scopolamine-induced memory impairment in adult male rats
by: Abdolkarim Hosseini, et al.
Published: (2016-04-01) -
CFTR Modulator Therapy for Rare CFTR Mutants
by: Marco Mergiotti, et al.
Published: (2022-04-01)